gland responsive to the action of ovarian hormones in the absence of the pituitary hormones (Ahrén 8c Jacobsohn, 1956, Ahrén 8c Etienne, 1958) . The question then arose as to whether treatment of hypophysectomized rats with insulin could also change the response of the mammary gland to testosterone.
In order to investigate this question it seemed necessary to obtain more information about the type and extent of mammary gland development pro¬ duced in rats with intact pituitary gland by different doses of testosterone administered over various periods of time. With regard to the controversial reports mentioned above the effect of testosterone on the mammary glands of hypophysectomized rats was also reinvestigated.
in the present work the effect of various doses of testosterone propionate on the rat mammary gland has been studied in 3 groups of animals: f) castrated, female and male rats. II) castrated, hypophysectomized female and male rats, III) castrated, hypophysectomized female and male rats treated with a longacting insulin.
EXPERIMENTAL
Male and female rats from a closed colony kept at our Institute were used. The animals belonged to the same colony that had provided rats for previous work (Ahrén Se Jacob¬ sohn, 1956, Ahrén 8c Etienne, 1957 Etienne, , 1958 (Vitrum) .
In addition, some rats, only castrated or castrated and hypophysectomized, were injected with the solvent of testosterone (arachis oil). Furthermore, some of the castrated hypophysectomized rats treated with testosterone were injected with zinc protamine suspension (= control preparation to zinc protamine insulin).
The animals were castrated at 3 to 4 weeks of age. Hypophysectomy was performed by the parapharyngeal route 5 to 47 days after castration, generally 2 to 4 weeks after castration. Serial sections through the hypophysial capsule and adjacent tissues, in¬ cluding the pituitary stalk and median eminence, were carefully searched for remnants of the pituitary gland. Only completely hypophysectomized rats are included in the tables. A few rats with pituitary remnants are discussed under »Results«.
Testosterone propionate (Neohombreol, Organon, 25 and 50 mg./ml.) was injected intramuscularly in doses of 2.5 mg. daily, 0.5 mg. every other day or daily, and 0.05 mg. daily. The volume administered daily was 0.02 ml. for all animals but for the 2.5 mg. dose given in 0.05 ml. For the dose of 0.05 mg., Neohombreol 25 mg./ml. was diluted 1 : 10 with arachis oil. Rats with intact pituitary gland received the first injection of testosterone 2-12 weeks after castration (see »Results«). In the hypophys¬ ectomized rats the treatment was started 19-63 days after hypophysectomy, with a majority of the experiments starting about 3 weeks after hypophysectomy.
The injections of zinc protamine insulin (40 I. U. per ml., Vitrum) were begun simultaneously with those of testosterone. Increasing doses of insulin were given sub¬ cutaneously according to the following scheme: 1 I. U. for 2 days, 2 I. U. for 4 days and 4, 6, 8, and 12 I. U. for 6 days each. Insulin was given once daily at about noon. Some rats were injected daily with a control preparation to insulin (zinc protamine suspension, Vitrum) in amounts equal to those of the insulin preparation. A 1.0 ml. tuberculin syringe was used for all the injections. In the insulin experiments the period of injections was limited by the capability of the rats to survive the treatment. The insulin treated animals were killed when they showed severe hypoglycemia, but some of them died during the night, and were then dissected early in the morning. Details about the period of the treatment are given under »Results« and in the tables.
Before the start of injections, the third right thoracic mammary gland was extirpated for whole mount preparation. This gland is referred to as the »control gland«. The third left thoracic gland was taken for whole mount preparation during the period of injections or at the end of the experiment. This gland is referred to as »experimental gland«. In most of the rats the injections were continued after the extirpation of the third left thoracic gland. In these rats, abdominal and/or inguinal glands were later removed and examined. These glands are also referred to as »experimental glands«. In all experiments the third left thoracic gland was removed as the first experimental gland.
In most of the experiments, paraffin sections of mammary glands were studied. These sections were made from abdominal, inguinal or second thoracic glands removed in the course of the treatment (see »Results«),
The staining methods, and the histological techniques used for the whole mount preparations and the paraffin sections, as well as the criteria used in assessing the changes in the mammary glands were the same as in previous investigations (Ahrén 8: Etienne, 1957 , 1958 The microscopic appearance of the paraffin sections is described under »Results«.
The rats were weighed before each operation and at least once a week during the period of injections. At autopsy, the uterus or the prostate and seminal vesicles were examined, and, in most of the experiments, the weight ol the liver and of the adrenal glands was recorded.
RESULTS
As mentioned above, different doses of testosterone propionate were used. The observations made on each of the 3 groups of rats will be described according to the following order of testosterone doses: A) 0.5 mg. every other day, B) 0.5 mg. daily, C) 2.5 mg. daily and D) 0.05 mg. daily. (Ahrén 8c Etienne, 1957) .
With the method used it was not possible to observe any major influence of the testosterone treatment on the mammary gland area. The stimulating effect of the treatment on the mammary glands was qualita¬ tively the same in the males and the females. Quantitatively the alveolar development was slightly more marked in the glands from the male rats. In all the female rats the nipples grew during the treatment (the males have no nipples).
The type and extent of mammary gland changes was the same in the younger rats, which received the first injection 2-3 weeks after castration, as in the older rats, which received the first injection 6-8 weeks after castration.
All the rats gained in weight during the treatment. At autopsy, the prostate and the seminal vesicles were large in the male rats, and the seminal vesicles contained thick, yellow secretion. In the females the uteri were markedly enlarged. (Fig. 15) . In the glands of the 4 female rats, the secretion was less marked. The ducts and alveoli were only slightly dilated, and no cyst formations were found in spite of more than 60 days of injections (Fig. 16) After treatment for 13-22 days the experimental mammary glands presented thick ducts which began to be covered with small groups of compact alveoli. Paraffin sections showed that these ducts and alveoli were lined by 1, 2 or 3 layers of large epithelial cells (Fig. 17) . Only few of the cells had vacuoles in the cytoplasm. The lumina of the ducts and alveoli were narrow. These mam¬ mary glands were very similar to those found in normal male rats at the age of 84-93 days (Ahrén 8c Etienne, 1957).
After treatment for about 50 days, the glands appeared very thick and compact. The ducts were covered with dense clusters of alveoli. The epithelium, lining ducts and alveoli, was composed of several layers of large epithelial cells (Fig. 18) . In many parts of these glands the ducts and alveoli appeared as solid cords and clumps of large cells. In fact, these glands presented the same picture as glands from normal male rats at the age of 98-115 days (Ahrén 8c Etienne, 1957 Fig. 7 ). All the experimental glands showed a thickening of the ducts (compare Fig. 8 ). This thickening was clearly seen in the whole mount preparations and already occurred after 9 days of treatment, fn most of the rats the experimental glands seemed to have a few more side buds than the control glands. Since small but thin branches, present in the control glands, were seen more distinctly in the experimental glands because of the general thickening of the ducts, it was not possible to determine whether there was a real increase in the number of the duct branches. In some of the experimental glands the terminal ducts were markedly swollen and seemed to be composed either of clusters of small ducts or of groups of small alveoli. The glands did not present a clear lobulealveolar development comparable with that found in group I. Paraffin sections revealed that the thickening of the ducts in the experi¬ mental glands was due to an increase in size and number of the epithelial cells and to a slight dilatation of the ducts (Fig. 20) . The (Fig. 21 ). In the 3 female rats the nipples grew during the treatment.
During the injection period the body weight increased in 7 rats, remained unchanged in 1 rat and decreased slightly in the remaining 3 animals (Table 1) . For all 11 rats there was an increase in body weight by an average of 7.1°/o. The weight of both adrenal glands was 6.8 ± 0.51 mg. (10)* or 6.0 ± 0.39 mg.
per 100 gm. body weight. The weight of the liver was 4.0 ± 0.24 gm. (10) or 3.5 ±0.13 gm. per 100 gm. body weight. The prostate and seminal vesicles were enlarged in the males, and in the females the uterus had increased in size.
// B: 0.5 mg. daily (Table 2) .
Nine completely hypophysectomized rats were injected daily with 0.5 mg. (Fig. 9) . Paraffin sections of 17 mammary glands were studied after treatment for 9 to 87 days. After short periods of injections (9-12 days) the ducts showed an increase in size and number of the epithelial cells and also a slight dilatation as described for group II A. However, even after this short period of in¬ jections the dilatation of the ducts was more pronounced in the present group than in group II A. After longer periods of treatment, the dilatation became extensive and the epithelial cells lining the ducts were flattened. Sections of glands extirpated after 2-3 months of treatment presented large cyst forma¬ tions (Fig. 22) . The inner wall of these cysts was generally lined by a thin layer of flattened epithelial cells. In some of the cysts the epithelium showed a peculiar folding and papillomatous growth into the lumina.
Before the start of injections the nipples were very small in the 5 female rats. In fact, it was often difficult to detect them. As early as after 2-3 weeks of treatment the nipples were more developed. After 2-3 months of injections the nipples were extremely long (3-4 mm.) but remarkably thin. The nipples of these castrated hypophysectomized rats were longer but thinner than those of the castrated rats of group I B.
During the period of injections the body weight increased in 7 rats. In 1 rat it remained unchanged and in another one it decreased slightly (Table 2) . In all 9 rats there was an increase in body weight by 13.4°/o (average). The weight of both adrenal glands was 6.3 ± 0.81 mg. (9) or 7.2 ± 0.56 mg. per 100 gm. body weight, and that of the liver 2.8 ± 0.27 gm. (9) Paraffin sections of 7 mammary glands showed that the thickening of the ducts was due merely to an increase in size and number of the epithelial cells (Fig. 24) . In most of the ducts the epithelium was composed of more than one layer of large cells, and the lumina of the ducts appeared obstructed (Fig. 24) (Table 4) .
Four completely hypophysectomized rats were injected with 0.02 ml. arachis 3-8. 2) The schedule of insulin was: 1, 2 and 4 LU., each of these doses for 2 days, 6 I. U. for 3 days, and finally 8 I. U.
mental« (see Table 6 ). (Fig. 25) . The body weight increased in both rats during treatment (Table 3) Most of the rats in group I were treated with higher doses of testosterone propionate (0.5 mg. every other day, 0.5 mg. daily or 2.5 mg. daily). With these higher doses too, a lobule-alveolar development was produced in the mammary glands, but in addition, these doses stimulated secretion (Figs. 12-16 ). Both ducts and alveoli were therefore more or less distended with secretion, fn these distended ducts and alveoli, the proliferation of the epithelial cells was less marked than in the glands from rats treated with 0.05 mg. daily. The degree of secretion increased with the dose and the period of testosterone treatment.
Cyst formations were found in the mammary glands of male rats injected daily with 0.5 or 2.5 mg. testosterone propionate for long periods (Fig. 15) Folley, 1952 Jemes, 1950) . A possible explanation might therefore be that high doses of oestrogens or androgens interfere with the secretion of the anterior pituitary hormones involved in the normal mammary gland development.
In group I, cyst formations were seen only in the glands of male rats (Fig.  15) . In the mammary glands of the female rats, injected for long periods with the higher doses of testosterone, both ducts and alveoli were distended with secretion but real cyst formations were not found (Fig. 16 ). This observation is in agreement with that of Uylderl (1951) , who found mammary cyst forma¬ tions after high doses of testosterone propionate (3 mg. daily) in castrated male rats but not in castrated female rats. We have, however, incidentally observed real cyst formations in the mammary glands of a female castrated rat injected daily with 10 mg. testosterone propionate for 32 days. Differences in cyst formation in male and female mammary glands have been reported to occur after treatment with oestrogens too. Uyldert (1951) found cyst forma¬ tions in the male but not in the female glands after daily injections with hand, reported cystic changes in the female glands too after daily injections with 100-200 µ%. of oestrone for 3-8 weeks. Thus, it seems that cystic forma¬ tions are formed more easily in the male than in the female glands. The cause of this difference between the reaction of the male and female glands is obscure. It might be due to the fact that the mammary glands of the male rats have no nipples and therefore no outlet for the secretion, which can accumulate more readily in the male than in the female glands.
With the method used it was not possible to detect an effect of the testosterone treatment on the extension of the mammary duct system. Club-shaped end buds, characteristic of the oestrogen-stimulated mammary gland, were not developed as a result of the testosterone treatment. It therefore seems unlikely that the effect of testosterone should have been produced by oestrogens occurring during the metabolism of testosterone.
Mammary gland responses to androgens have also been studied in other species. For the mouse and the guinea-pig it has been reported that testosterone induced a slight growth of the mammary ducts but hardly any development of alveoli (for lit. see Folley, 1952 The observations made in group II confirm those of Leonard (1943) who found a thickening and dilatation of the mammary ducts of hypophysectomized rats injected with testosterone propionate for a period of up to 16 days. In the present work, castrated hypophysectomized rats were treated with three different doses of testosterone propionate for periods varying from 7 to 90 days. As in group I, considerable differences were found in the mammary gland responses to the different doses of testosterone propionate. The smallest dose (0.05 mg. daily) produced a marked thickening of the mammary duct system, which was due to a proliferation (= hypertrophy and hyperplasia) of the ductal epithelial cells (Fig. 24) . The 0.05 mg. dose elicited only slight secretion which did not increase during periods of treatment of up to 2-3 months. The higher doses (0.5 mg. every other day or daily) produced proliferation of the epithelial cells as well as secretion (Figs. 19-22) . After long periods of injections the secretory changes were more striking than the epithelial proliferation. After daily injections of 0.5 mg. of testosterone propionate for 2-3 months some parts of the duct system were transformed into cystic formations (Fig. 22 Recently Ahrén 8c Jacobsohn (1957) observed that cortisone promoted pro¬ liferation of the ductal epithelial cells and secretion in the mammary glands of hypophysectomized rats. Experiments on parabiotic rats (Jacobsohn, 1949) indicate that endogenously produced adrenocortical hormones can exert the same action on the mammary ducts as cortisone. The question then arises whether the mammary gland changes of the hypophysectomized testosterone treated rats can be explained as an effect of adrenocortical hormones. That testosterone has an effect on the adrenal glands of hypophysectomized rats was found by many investigators (for lit. see Zuckerman, 1953 , Courrier et al, 1953 . Testosterone injections, when started immediately after hypophysectomy, partially prevented the adrenal atrophy which results from the removal of the pituitary gland. When the treatment was started after post-operative inter¬ vals of 2-3 weeks, it had no influence on the adrenal weight but a slight stimulating effect on the cells of the adrenal cortex. In the present work, the testosterone treatment was instituted at about 3 weeks after hypophysectomy, and the adrenal glands were quite atrophie (judged from the weight) after the treatment. It seems therefore unlikely that an increased secretion of adrenal cortical hormones plays a significant role in the mammary gland changes found in the hypophysectomized rats after testosterone treatment. This assumption is supported by the observation of Ahrén 8c Jacobsohn (1957) (Kochakian, 1950 (1947) found that testosterone failed to promote a significant body weight gain in hypophysectomized rats in spite of a nitrogen retention, in the present investigation many of the hypophysectomized rats gained in weight during the testosterone treatment, in group II this weight gain can only partly be attributed to testosterone, since these rats weighed less than 100 gm. at hypophysectomy. In our colony, rats hypophys¬ ectomized when younger than 5 to 6 weeks and weighing less than 100 gm., usually gain slightly in weight without any treatment. In group II A most of the rats weighed more than 100 gm. at hypophysectomy, and many of these rats also gained slightly in weight during the treatment. However, the small number of control rats (group II E) does not allow of any conclusions re¬ garding the body weight changes.
The mammary gland response to testosterone bears some resemblance to that of the sebaceous glands. Lasher et al. (1954) and with ovarian hormones combined with prolactin or placental extracts (Lyons, 1951 , Lyons el al, 1955 (Salter et al., 1957) . In the present work all the hypophysectomized rats treated with zinc protamine in¬ sulin gained in weight during the treatment. Whether the addition of testo¬ sterone was more effective than insulin alone in increasing the body weight in the hypophysectomized rats, can not be inferred from the experiments of the present work. Fig. 2t 
